Aarti Drugs’s stock witnessed a significant rise of 16.30% after the company’s board approved a buyback of shares at ₹900 per share, representing 0.72% of the existing paid-up capital.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
